NEW YORK (Reuters Health) - Taking aspirin may reduce the risk of Covid-19 patients from becoming more severely ill or dying, a new study suggests.
Researchers have found that low-dose daily supplements can reduce the rate of oxygen consumption or prevent more than 40 percent of ICU entry.
In addition, it reduced the risk of dying from infection by almost half compared to people who did not take the drug.
A team led by George Washington University School of Medicine says research shows that aspirin can be quicker, easier and cheaper than other drugs.
"The reason we started taking aspirin with Covid-19 was because most patients would start having summer suffocation complications," said Dr Jonathan Chow.
At the same time, experts believe that aspirin's ability to prevent blood clots may be beneficial to Covid patients.
The study, published in the journal Anesthesia & Analgesia, looked at 412 Covid-19 patients who were hospitalized in the United States between March 2020 and July 2020. Of those, 314 (76.3%) did not receive aspirin and the remaining 98 (23.7) received medication within 24 hours of admission.
The results showed that 44% of patients who took aspirin did not need oxygen and 43% were not at risk of entering the ICU.
In addition, 47% of those who received the drug did not appear to have died of Covid-19 in the hospital.
"Aspirin use may improve patient outcomes while in the hospital," the authors concluded.
Meanwhile, another study found that one tablet of aspirin a day reduced the risk of Covid-19 infection by 29 percent.
No comments:
Post a Comment